As of 2025-09-18, the Intrinsic Value of Chemed Corp (CHE) is 616.61 USD. This CHE valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 457.36 USD, the upside of Chemed Corp is 34.80%.
The range of the Intrinsic Value is 451.31 - 1,021.12 USD
Based on its market price of 457.36 USD and our intrinsic valuation, Chemed Corp (CHE) is undervalued by 34.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 451.31 - 1,021.12 | 616.61 | 34.8% |
| DCF (Growth 10y) | 562.58 - 1,219.98 | 754.65 | 65.0% |
| DCF (EBITDA 5y) | 557.84 - 683.21 | 624.56 | 36.6% |
| DCF (EBITDA 10y) | 663.12 - 857.39 | 760.19 | 66.2% |
| Fair Value | 168.54 - 168.54 | 168.54 | -63.15% |
| P/E | 470.29 - 685.91 | 533.40 | 16.6% |
| EV/EBITDA | 411.89 - 546.12 | 476.11 | 4.1% |
| EPV | 305.33 - 410.42 | 357.88 | -21.8% |
| DDM - Stable | 121.06 - 341.19 | 231.13 | -49.5% |
| DDM - Multi | 205.56 - 463.09 | 286.10 | -37.4% |
| Market Cap (mil) | 6,663.74 |
| Beta | 0.39 |
| Outstanding shares (mil) | 14.57 |
| Enterprise Value (mil) | 6,414.14 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.39% |
| Cost of Debt | 4.48% |
| WACC | 6.91% |